Clinical evaluation of Bametan.
D000284:Administration, Oral; D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D001808:Blood Vessels / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D004341:Drug Evaluation; D004983:Ethanolamines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007866:Leg / Q000098:blood supply; D008297:Male; D008875:Middle Aged
D004983:Ethanolamines